Updated on 8 June 2016
Singapore: UK based Avita Medical recently announced its collaboration with Asia-Pacific's specialized wound care product distributor-Mintcare. As per the terms, Mintcare will distribute Avita's wound care products throughout the Asia-Pacific region, with an initial focus on Malaysia.
The company also said that it planned to launch its ReCell products at an international wound care conference in Sabah, Malaysia in August this year. Earlier this year, Avita had also inked an exclusive distribution deal with Chinese healthcare group Sinopharm. The deal provided Sinopharm's MedTech subsidiary with exclusive distribution rights for the range of Avita's medical devices, including regenerative treatments for burns, chronic wounds and skin defects.
Avita's CEO Mr Adam Kelliher, said in a press release, "The deal with Mintcare will give Avita Medical an active presence to deliver our innovative treatments to Malaysia, a market of 30 million people, and further underscores the significance of the broader Asian healthcare market for our company. We will keep developing our distributor network in the region so that we are well-placed to address the significant commercial opportunities in Avita."
"The addition of ReCell to the Mintcare product portfolio brings great synergistic opportunities. Mintcare has successfully developed a distribution network in South East Asia specifically in the chronic wound care field, primarily targeting diabetic foot ulcers and venous leg ulcers with topical oxygen therapy. We're confident our many years of experience in this industry and our in-depth knowledge of the local environment and culture, will deliver success to ReCell in Malaysia," said Mr Lamine Guendil, , Mintcare director.